What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?

Archives of Disease in Childhood

Volumn 92, Issue 2, 2007, Pages 165-169

  Aneja, Rajesh ^b   Carcillo, Joseph A ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CATECHOLAMINE; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE;

ACUTE STRESS DISORDER; ADDISON DISEASE; ADRENAL INSUFFICIENCY; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE TITRATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; REVIEW; SEPTIC SHOCK; SIDE EFFECT; SPINAL CORD INJURY;

ADRENAL INSUFFICIENCY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYDROCORTISONE; SHOCK, SEPTIC;

EID: 33847011752     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.088450     Document Type: Review

References (61)

1. Addison T. On the constitutional and local effects of disease of the supra-renal capsules. Lond Med Gaz 1849;43:517-18.
2. Wilson L. Internal secretions in disease: the historical relations of clinical medicine and scientific physiology. J Hist Med Allied Sci 1984;39:263-302.
3. Greenhow B. Addison's disease. London: JW Roche, 1866.
4. Oliver G, Schafer E. The physiological effects of extracts of the suprarenal capsules. J Physiol 1895;18:230-76.
5. Voelcker A. Abstract of post mortem report. Middlesex Hospital Rep Med Surg Path Rregistrars 1894:278.
6. Waterhouse R. A case of suprarenal apoplexy. Lancet 1911;1:577-8.
7. Friderichsen C. Waterhouse-Friderichsen syndrome. Acta Endocrinol Suppl (Copenh) 1955;18:482-92.
8. Von Fiirth O. The catechol-like substance of the suprarenal. J Chem Soc Abstr 1900;78:292.
9. Takamine J. Adrenalin, the active principle of the suprarenal glands and its mode of preparation. Am J Pharm 1901;73:523-31.
10. Aldrich T. A preliminary report on the active principle of the suprarenal gland. Am J Physiol 1901;5:457-61.
11. Muirhead A. An autograph history of a cose of Addison's disease. J Am Med Assoc 1922;79:556-7.
12. Rownfree L. Subsequent course of a case of Addison's disease. J Am Med Assoc 1922;79:556-7.
13. Smith P. J Am Med Assoc 1927;66:158.
14. De Crecchio L. Sopra un caso di apparenzi virili in una donna. Morgagni 1865;7:154-88.
15. Lillehei R, MacLean L. Physiological approach to successful treatment of endotoxin shock in the experimental animal. Arch Surg 1959;78:464.
16. Kass EH, Finland M. Adrenocortical hormones in infection and immunity. Annu Rev Microbiol 1953;7:361-88.
17. Kass EH, Finland M. Adrenocortical hormones and the management of infection. Annu Rev Med 1957;8:1-18.
18. Kass EH, Finland M. Corticosteroids and infections. Adv Intern Med 1958;9:45-80.
19. Robinson HJ. Adrenal steroids and resistance to infection. Antibiot Chemother 1960;7:199-240.
20. Migeon C. Adrenal steroid therapy. In: Rudolph A, Barnett H, Einhorn A, eds. Pediatrics, 16th edn. New York: Appleton-Century-Crofts, 1977:1651-62.
21. McEvoy G. Hormones and synthetic substitutes, The American Hospital Formulary. Bethesda: American Society of Health-System Pharmacists, 1998, 68, 04-08.
22. Singh UK, Jana UK. Serum prolactin and cortisol in children with some paroxysmal disorders. Indian J Pediatr 1994;61:57-61.
23. Nickels DA, Moore DC. Serum cortisol responses in febrile children. Pediatr Infect Dis J 1989;8:16-20.
24. Schein RM, Sprung CL, Marcial E, et al. Plasma cortisol levels in patients with septic shock. Crit Care Med 1990;18:259- 63.
25. Riordan FA, Thomson AP, Ratcliffe JM, et al. Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: evidence of adrenal insufficiency? Crit Care Med 1999;27:2257-61.
26. Min M, UT, Aye M, et al. Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975;6:573-9.
27. Weitzman S, Berger S. Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med 1974;81:36-42.
28. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984;311:1137-43.
29. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659- 65.
30. Bone RC, Fisher CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
31. Hinshaw LB, Beller BK, Chang AC, et al. Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock 1985;16:265-77.
32. Claussen MS, Landercasper J, Cogbill TH. Acute adrenal insufficiency presenting as shock after trauma and surgery: three cases and review of the literature. J Trauma 1992;32:94-100.
33. Lee LM, Gumowski J. Adrenocortical insufficiency: a medical emergency. AACN Clin Issues Crit Care Nurs 1992;3:319-30.
34. Briegel J, Kellermann W, Forst H, et al. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Invest 1994;72:782-7.
35. Bouachour G, Tirot P, Gouello JP, et al. Adrenocortical function during septic shock. Intensive Care Med 1995;21:57-62.
36. Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995;98:266- 71.
37. Briegel J, Schelling G, Haller M, et al. A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996;22:894-9.
38. Aygen B, Inan M, Doganay M, et al. Adrenal functions in patients with sepsis. Exp Clin Endocrinol Diabetes 1997;105:182-6.
39. Duggan M, Browne I, Flynn C. Adrenal failure in the critically ill. Br J Anaesth 1998;81:468-70.
40. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9.
41. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
42. Pizarro CF, Troster EJ, Damiani D, et al. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med 2005;33:855-9.
43. Casartelli CH, Garcia PC, Piva JP, et al. Adrenal insufficiency in children with septic shock. J Pediatr (Rio J) 2003;79(Suppl 2):S169-76.
44. De Kleijn ED, Joosten KF, Van Rijn B, et al. Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002;21:330-6.
45. Joosten KF, de Kleijn ED, Westerterp M, et al. Endocrine and metabolic responses in children with meningoccocal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 2000;85:3746-53.
46. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
47. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
48. Annane D, Sebille V, Bellissant E. Corticosteroids for patients with septic shock. JAMA 2003;289:43-4.
49. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology 1984;61:647-51.
50. Wagner RL, White PF, Kan PB, et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984;310:1415-21.
51. den Brinker M, Joosten KF, Liem O, et al. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005;90:5110-17.
52. Annane D. ICU physicians should abandon the use of etomidate. Intensive Care Med 2005;31:325-6.
53. Morris B, McAllister C. Etomidate for emergency anaesthesia; mad, bad and dangerous to know? Anaesthesia 2005;60:737-40.
54. Hatherill M, Tibby SM, Milliard T, et al. Adrenal insufficiency in septic shock. Arch Dis Child 1999;80:51-5.
55. Markovitz BP, Goodman DM, Watson RS, et al. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids? Pediatr Crit Care Med 2005;6:270-4.
56. Rix M, Birkebaek NH, Rosthoj S, et al. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropic test. J Pediatr 2005;147:645-50.
57. Liddle GW, Estep HL, Kendall JW Jr, et al. Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab 1959;19:875-94.
58. Berneis K, Staub JJ, Gessler A, et al. Combined stimulation of adrenocorticotropic and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 2002;87:5470-5.
59. Ng PC, Lee CH, Bnur FL, et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics 2006;117:367-75.
60. Committee on Fetus and N. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-8.
61. Lodygensky GA, Rademaker K, Zimine S, et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005;116:1-7.